explore -WSS

explore

author：comprehensive 2025-09-28 05:04:37 - browse：986

Jeremey Wyatt ActiGraph

As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry.

The Pensacola, Fla.-based company creates devices and software explicitly designed for clinical trials by focusing on features that matter to sponsors, like bulletproof reliability, access to raw sensor data, and 30-day battery life so that trial participants never have to worry about charging devices.

There are many potential advantages to using wearables in clinical trials. Continuous data may collect a more comprehensive picture of how a patient responds to treatment and could help drugmakers complete trials faster with fewer participants. But risk-averse companies have been slow to adopt the technology and opt instead for the certainty of established methods for capturing data. The industry has yet to see a drug approved with evidence from a wearable device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Trump used to be more articulate. What could explain the change?

WSS

NFL doctors' conflicts of interest could endanger players, report says

The United States must get value

Boston hospital trains restaurant workers on naloxone for overdoses

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

It was time to plan for my old age. If only I could stop crying

leisure time

explore

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Abbott's new stent may help patients with peripheral artery disease

In age of alternative facts, a scholarly course on calling out crap

Tuberculosis patients need more than just free medication

Psychedelics group wrestles with new pharma identity

The United States must get value

23andMe had bad news about my health. I wish a person had delivered it

STAT series 'Denied by AI' wins major journalism prizes

Anesthesiologist group: stop taking Ozempic before surgery

CVS is willing to dump 10% of its Medicare Advantage members

Wikipedia

Cherokee Nation medical school graduates its first class

St. Louis police protesters begin picking up checks in $4.9 million settlement

Supreme Court to hear if Covid misinformation is protected speech

STAT reporters are Pulitzer Prize finalists for investigative reporting

Galapagos to make CAR

Hottest summer in 2,000 years puts focus on extreme heat, health

leisure time

knowledge

explore

entertainment